Search research articles
Contact Us
Filters
Showing results (251-260 of 258) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 258 results.
Scientific Reports
|
September 21, 2017
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard
J A Livingston, D Bugano, A Barbo, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Annals of Internal Medicine
|
May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer
S Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas
J B Fleming, R S Berman, S C Cheng, et al.
Scientific Reports
|
September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response
R F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Cancer Treatment Reports
|
February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas
J A Gottlieb, R S Benjamin, L H Baker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 258) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 258 results.
Scientific Reports
|
September 21, 2017
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard
J A Livingston, D Bugano, A Barbo, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Annals of Internal Medicine
|
May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer
S Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas
J B Fleming, R S Berman, S C Cheng, et al.
Scientific Reports
|
September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response
R F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Cancer Treatment Reports
|
February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas
J A Gottlieb, R S Benjamin, L H Baker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Page
of 26